<div id="readability-page-1"><p>Avanza Fonder AB grew its holdings in shares of  Procter &amp; Gamble Company (The) (NYSE:PG - Free Report) by 4.2% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 244,600 shares of the company's stock after purchasing an additional 9,934 shares during the period. Procter &amp; Gamble accounts for  1.0% of Avanza Fonder AB's portfolio, making the stock its 13th biggest position. Avanza Fonder AB's holdings in Procter &amp; Gamble were worth $37,583,000 as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Procter &amp; Gamble</strong> alerts:</span></p></div><ul><li>3 Smart Defensive Stocks for an Uneasy Market</li></ul><p>A number of other large investors also recently modified their holdings of PG. Nova Wealth Management Inc. bought a new position in  Procter &amp; Gamble in the first quarter worth about $26,000.  Signature Resources Capital Management LLC raised its position in shares of  Procter &amp; Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock worth $28,000 after purchasing an additional 72 shares during the period.  Quarry LP bought a new stake in shares of  Procter &amp; Gamble in the 1st quarter worth approximately $33,000.  Mid American Wealth Advisory Group Inc. acquired a new position in  Procter &amp; Gamble during the 2nd quarter valued at approximately $34,000.  Finally, RMG Wealth Management LLC bought a new position in  Procter &amp; Gamble during the 2nd quarter worth $37,000. 65.77% of the stock is currently owned by institutional investors. </p><h2>Analyst Upgrades and Downgrades</h2><p>PG has been the topic of a number of recent research reports. Weiss Ratings  reiterated a &#34;hold (c)&#34; rating on shares of Procter &amp; Gamble in a research note on Monday. Wells Fargo &amp; Company cut their price objective on shares of Procter &amp; Gamble from $173.00 to $170.00 and set an &#34;overweight&#34; rating on the stock in a research report on Thursday, September 25th. Morgan Stanley  set a $175.00 target price on shares of Procter &amp; Gamble in a research note on Monday, October 27th. Berenberg Bank raised their price target on shares of Procter &amp; Gamble from $152.00 to $154.00 and gave the company a &#34;hold&#34; rating in a research note on Wednesday, September 17th. Finally, Dbs Bank raised Procter &amp; Gamble to a &#34;hold&#34; rating in a report on Friday, December 5th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued  a Hold rating to the stock. According to MarketBeat, Procter &amp; Gamble presently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $171.38.</p><ul><li>MarketBeat Week in Review – 10/27 - 10/31</li></ul><p><b>Check Out Our Latest Stock Analysis on PG</b></p><h2>Insider Buying and Selling at Procter &amp; Gamble</h2><p>In related news, CAO Matthew W. Janzaruk sold 725 shares of the firm's stock in a transaction that occurred on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the sale, the chief accounting officer directly owned 979 shares in the company, valued at approximately $146,429.03. This trade represents a 42.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the company's stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the transaction, the chief operating officer directly owned 46,899 shares in the company, valued at $7,139,434.77. This represents a 7.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 30,308 shares of company stock valued at $4,611,852. Corporate insiders own  0.20% of the company's stock. </p><h2>Procter &amp; Gamble Stock Up 0.9%</h2><ul><li>Wayfair: A Way Good Stock to Buy and Hold for 2026</li></ul><p>Shares of PG stock opened at $144.53 on Friday. Procter &amp; Gamble Company has a 1 year low of $138.14 and a 1 year high of $179.99. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The business's fifty day moving average is $146.94 and its 200-day moving average is $152.97. The stock has a market cap of $337.72 billion, a PE ratio of 21.10, a price-to-earnings-growth ratio of 4.87 and a beta of 0.39. </p><p>Procter &amp; Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating the consensus estimate of $1.90 by $0.09. Procter &amp; Gamble had a return on equity of 32.63% and a net margin of 19.74%.The business had revenue of $22.39 billion during the quarter, compared to analysts' expectations of $22.23 billion. During the same quarter last year, the business posted $1.93 earnings per share. The company's quarterly revenue was up 3.0% on a year-over-year basis. Procter &amp; Gamble has set its FY 2026 guidance at 6.830-7.100 EPS.  Equities analysts expect that  Procter &amp; Gamble Company will post 6.91 earnings per share for the current fiscal year. </p><h2>Procter &amp; Gamble Dividend Announcement</h2><p>The firm also recently announced a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Friday, October 24th were issued a $1.0568 dividend. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date was Friday, October 24th. Procter &amp; Gamble's payout ratio is presently 61.75%. </p><h2>Procter &amp; Gamble Company Profile</h2> (Free Report)<p>Procter &amp; Gamble <span>NYSE: PG<span></span></span> is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&amp;G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.  </p><p>P&amp;G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric &amp; Home Care, and Baby, Feminine &amp; Family Care.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Procter &amp; Gamble</li><li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li><li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li><li>Washington prepares for war</li><li>Strange Crystal Metal Outperforms Silicon Up to 100X</li><li>33,000% boom from weird new “AI Fuel?”</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBH?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVBH"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Procter &amp; Gamble Right Now?</h2><p>Before you consider Procter &amp; Gamble, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter &amp; Gamble wasn't on the list.</p><p>While Procter &amp; Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Avanza Fonder AB increased its holdings in Procter & Gamble by 4.2% in Q3, owning 244,600 shares valued at $37.58 million. This makes PG the 13th largest position in Avanza's portfolio. Institutional investors own 65.77% of PG stock. Recent analyst ratings show a consensus of 'Moderate Buy' with a target price of $171.38. Insider trading included sales by CAO Matthew Janzaruk and COO Shailesh Jejurikar. PG stock opened at $144.53, with a market cap of $337.72 billion.</p>

Procter & Gamble Company (The) $PG Shares Purchased by Avanza Fonder AB